 | • レポートコード：GIR-2104Z10102 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、核医学・放射性医薬品のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。核医学・放射性医薬品の種類別市場規模（診断用放射性同位元素、治療用放射性同位元素）、用途別市場規模（腫瘍学、心臓病学、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・核医学・放射性医薬品の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bracco Imaging、Bayer、Mallinckrodt、Nordion、Triad Isotopes、Lantheus、IBA Group、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Advanced Accelerator Applications、SIEMENS、Dongcheng、Navidea ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：診断用放射性同位元素、治療用放射性同位元素 ・用途別分析2016年-2026年：腫瘍学、心臓病学、その他 ・核医学・放射性医薬品の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・核医学・放射性医薬品のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・核医学・放射性医薬品のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・核医学・放射性医薬品の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・核医学・放射性医薬品の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Nuclear Medicine & Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Nuclear Medicine & Radiopharmaceuticals size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Nuclear Medicine & Radiopharmaceuticals market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Nuclear Medicine & Radiopharmaceuticals market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Market segment by Application can be divided into
Oncology
Cardiology
Other
The key market players for global Nuclear Medicine & Radiopharmaceuticals market are listed below:
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Nuclear Medicine & Radiopharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Market Analysis by Application
1.3.1 Overview: Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Nuclear Medicine & Radiopharmaceuticals Market Size & Forecast
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Value (2016-2026))
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume (2016-2026)
1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)
1.5 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity Analysis
1.5.1 Global Nuclear Medicine & Radiopharmaceuticals Total Production Capacity (2016-2026)
1.5.2 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nuclear Medicine & Radiopharmaceuticals Market Drivers
1.6.2 Nuclear Medicine & Radiopharmaceuticals Market Restraints
1.6.3 Nuclear Medicine & Radiopharmaceuticals Trends Analysis
2 Manufacturers Profiles
2.1 Bracco Imaging
2.1.1 Bracco Imaging Details
2.1.2 Bracco Imaging Major Business
2.1.3 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Services
2.1.4 Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Bayer
2.2.1 Bayer Details
2.2.2 Bayer Major Business
2.2.3 Bayer Nuclear Medicine & Radiopharmaceuticals Product and Services
2.2.4 Bayer Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business
2.3.3 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Services
2.3.4 Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Nordion
2.4.1 Nordion Details
2.4.2 Nordion Major Business
2.4.3 Nordion Nuclear Medicine & Radiopharmaceuticals Product and Services
2.4.4 Nordion Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Triad Isotopes
2.5.1 Triad Isotopes Details
2.5.2 Triad Isotopes Major Business
2.5.3 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Services
2.5.4 Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Lantheus
2.6.1 Lantheus Details
2.6.2 Lantheus Major Business
2.6.3 Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Services
2.6.4 Lantheus Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 IBA Group
2.7.1 IBA Group Details
2.7.2 IBA Group Major Business
2.7.3 IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Services
2.7.4 IBA Group Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Services
2.8.4 GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 China Isotope & Radiation
2.9.1 China Isotope & Radiation Details
2.9.2 China Isotope & Radiation Major Business
2.9.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
2.9.4 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Services
2.10.4 Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Eli Lilly
2.11.1 Eli Lilly Details
2.11.2 Eli Lilly Major Business
2.11.3 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Services
2.11.4 Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Advanced Accelerator Applications
2.12.1 Advanced Accelerator Applications Details
2.12.2 Advanced Accelerator Applications Major Business
2.12.3 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Services
2.12.4 Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 SIEMENS
2.13.1 SIEMENS Details
2.13.2 SIEMENS Major Business
2.13.3 SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Services
2.13.4 SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Dongcheng
2.14.1 Dongcheng Details
2.14.2 Dongcheng Major Business
2.14.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
2.14.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Navidea
2.15.1 Navidea Details
2.15.2 Navidea Major Business
2.15.3 Navidea Nuclear Medicine & Radiopharmaceuticals Product and Services
2.15.4 Navidea Nuclear Medicine & Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer
3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Nuclear Medicine & Radiopharmaceuticals
3.4 Market Concentration Rate
3.4.1 Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share
3.4.2 Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer Market Share
3.5 Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2016-2026)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2026)
4.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)
4.3 Europe Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)
4.4 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)
4.5 South America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)
4.6 Middle East and Africa Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Type (2016-2026)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2026)
5.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Application (2016-2026)
6.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2026)
6.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)
7.2 North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)
7.3 North America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
7.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)
7.3.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)
8.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)
8.3 Europe Nuclear Medicine & Radiopharmaceuticals Market Size by Country
8.3.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)
8.3.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)
9.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)
9.3 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Market Size by Region
9.3.1 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)
10.2 South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)
10.3 South America Nuclear Medicine & Radiopharmaceuticals Market Size by Country
10.3.1 South America Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)
10.3.2 South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2026)
11.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2026)
11.3 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Market Size by Country
11.3.1 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Nuclear Medicine & Radiopharmaceuticals Typical Distributors
12.3 Nuclear Medicine & Radiopharmaceuticals Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type, (USD Million), 2021-2026
Table 2. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application, (USD Million), 2021-2026
Table 3. Bracco Imaging Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Imaging Major Business
Table 5. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 6. Bracco Imaging Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Major Business
Table 9. Bayer Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 10. Bayer Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mallinckrodt Basic Information, Manufacturing Base and Competitors
Table 12. Mallinckrodt Major Business
Table 13. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 14. Mallinckrodt Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Nordion Basic Information, Manufacturing Base and Competitors
Table 16. Nordion Major Business
Table 17. Nordion Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 18. Nordion Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Triad Isotopes Basic Information, Manufacturing Base and Competitors
Table 20. Triad Isotopes Major Business
Table 21. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 22. Triad Isotopes Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Lantheus Basic Information, Manufacturing Base and Competitors
Table 24. Lantheus Major Business
Table 25. Lantheus Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 26. Lantheus Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. IBA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBA Group Major Business
Table 29. IBA Group Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 30. IBA Group Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 32. GE Healthcare Major Business
Table 33. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 34. GE Healthcare Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table 36. China Isotope & Radiation Major Business
Table 37. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 38. China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 42. Jubilant Pharma Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Major Business
Table 45. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 46. Eli Lilly Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Advanced Accelerator Applications Basic Information, Manufacturing Base and Competitors
Table 48. Advanced Accelerator Applications Major Business
Table 49. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 50. Advanced Accelerator Applications Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. SIEMENS Basic Information, Manufacturing Base and Competitors
Table 52. SIEMENS Major Business
Table 53. SIEMENS Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 54. SIEMENS Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Dongcheng Basic Information, Manufacturing Base and Competitors
Table 56. Dongcheng Major Business
Table 57. Dongcheng Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 58. Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Navidea Basic Information, Manufacturing Base and Competitors
Table 60. Navidea Major Business
Table 61. Navidea Nuclear Medicine & Radiopharmaceuticals Product and Services
Table 62. Navidea Nuclear Medicine & Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Global Nuclear Medicine & Radiopharmaceuticals Sales by Manufacturer (2019-2021e) & (K Units)
Table 64. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 65. Market Position of Manufacturers in Nuclear Medicine & Radiopharmaceuticals, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 66. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Company, (K Units): 2020 VS 2021
Table 67. Head Office and Nuclear Medicine & Radiopharmaceuticals Production Site of Key Manufacturer
Table 68. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)
Table 69. Global Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)
Table 70. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 71. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 72. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 73. Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 74. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2016-2021e) & (USD Million)
Table 75. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Type (2021-2026) & (USD Million)
Table 76. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021e) & (USD/Unit)
Table 77. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2021-2026) & (USD/Unit)
Table 78. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 79. Global Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 80. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2016-2021e) & (USD Million)
Table 81. Global Nuclear Medicine & Radiopharmaceuticals Revenue by Application (2021-2026) & (USD Million)
Table 82. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2021e) & (USD/Unit)
Table 83. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2021-2026) & (USD/Unit)
Table 84. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 85. North America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 86. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 87. North America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 88. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 89. North America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 90. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 91. North America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 92. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 93. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 94. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 95. Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 96. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 97. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 98. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 99. Europe Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 100. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2016-2021e) & (K Units)
Table 101. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Region (2021-2026) & (K Units)
Table 102. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2016-2021e) & (USD Million)
Table 103. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue by Region (2021-2026) & (USD Million)
Table 104. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 105. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 106. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 107. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 108. South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 109. South America Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 110. South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 111. South America Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 112. South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 113. South America Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 114. South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 115. South America Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 116. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2016-2021e) & (K Units)
Table 117. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Country (2021-2026) & (K Units)
Table 118. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2016-2021e) & (USD Million)
Table 119. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue by Country (2021-2026) & (USD Million)
Table 120. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016-2021e) & (K Units)
Table 121. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Type (2021-2026) & (K Units)
Table 122. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2016-2021e) & (K Units)
Table 123. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales by Application (2021-2026) & (K Units)
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Nuclear Medicine & Radiopharmaceuticals Typical Distributors
Table 127. Nuclear Medicine & Radiopharmaceuticals Typical Customers
List of Figures
Figure 1. Nuclear Medicine & Radiopharmaceuticals Picture
Figure 2. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type in 2020
Figure 3. Diagnostic Radioisotopes
Figure 4. Therapeutic Radioisotopes
Figure 5. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application in 2020
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Global Nuclear Medicine & Radiopharmaceuticals Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Nuclear Medicine & Radiopharmaceuticals Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Nuclear Medicine & Radiopharmaceuticals Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Nuclear Medicine & Radiopharmaceuticals Sales (2016-2026) & (K Units)
Figure 31. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity (2016-2026) & (K Units)
Figure 32. Global Nuclear Medicine & Radiopharmaceuticals Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Nuclear Medicine & Radiopharmaceuticals Market Drivers
Figure 34. Nuclear Medicine & Radiopharmaceuticals Market Restraints
Figure 35. Nuclear Medicine & Radiopharmaceuticals Market Trends
Figure 36. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Manufacturer in 2020
Figure 37. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Manufacturer in 2020
Figure 38. Nuclear Medicine & Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Nuclear Medicine & Radiopharmaceuticals Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 42. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 43. North America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 44. Europe Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 46. South America Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue (2016-2026) & (USD Million)
Figure 48. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 49. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Type (2016-2026)
Figure 50. Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 52. Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Application (2016-2026)
Figure 53. Global Nuclear Medicine & Radiopharmaceuticals Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 55. North America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 56. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 57. North America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 58. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 59. Europe Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 60. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 61. Europe Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 66. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 67. South America Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 68. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 69. South America Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Nuclear Medicine & Radiopharmaceuticals Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の核心臓病学市場規模・現状・予測（2021年-2027年） Nuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular di…- 世界の原子炉市場規模・現状・予測（2021年-2027年） Nuclear reactors are devices designed to maintain a chain reaction producing a steady flow of neutrons generated by the fission of heavy nuclei. They are, however, differentiated either by their purpose or by their design features. In terms of purpose, they are either research reactors or power reac…
- 世界の核イメージングシステム市場 2021：企業別、地域別、種類・用途別 The Nuclear Imaging Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の核廃棄物リサイクル市場規模・現状・予測（2021年-2027年） Nuclear waste is recyclable. Once reactor fuel (uranium or thorium) is used in a reactor, it can be treated and put into another reactor as fuel. More than half of France's electricity comes from nuclear power and recycles used fuel. Other countries that use used fuels include the United Kingdom, Ru…
- 世界の原子力用超合金市場 2021：企業別、地域別、種類・用途別 The Superalloy for Nuclear market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…